TECH
$TECH
Bio-Techne Corporation
Life sciences company providing proteins, antibodies, and diagnostics for research.
HealthcareSubscribers
0
Tracking this ticker
Latest Report
Analysis from Mar 30, 2026
TECH: COMET Expansion, Valuation in Focus
Bio-Techne ($TECH) shows product-driven momentum with COMET and SPYRE expansions and strong analyst sentiment. High TTM valuation and mixed top-line trends make near-term upside conditional on execution.
Mar 30, 2026